Morgan Stanley
BME icon

Morgan Stanley’s BlackRock Health Sciences Trust BME Stock Holding History

Morgan Stanley’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8M Buy
357,918
+12,129
+4% +$500K ﹤0.01% 3289
2025
Q4 		$14.2M Buy
345,789
+16,856
+5% +$666K ﹤0.01% 3263
2025
Q3 		$12.2M Sell
328,933
-30,887
-9% -$1.12M ﹤0.01% 3364
2025
Q2 		$13.1M Sell
359,820
-9,111
-2% -$330K ﹤0.01% 3189
2025
Q1 		$14.3M Sell
368,931
-16,839
-4% -$668K ﹤0.01% 3017
2024
Q4 		$14.6M Sell
385,770
-10,045
-3% -$401K ﹤0.01% 3050
2024
Q3 		$16.6M Buy
395,815
+27,968
+8% +$1.16M ﹤0.01% 2978
2024
Q2 		$15M Sell
367,847
-16,866
-4% -$671K ﹤0.01% 2972
2024
Q1 		$15.9M Sell
384,713
-371,509
-49% -$15.6M ﹤0.01% 2936
2023
Q4 		$30.6M Buy
756,222
+415,922
+122% +$15.9M ﹤0.01% 2949
2023
Q3 		$13.3M Buy
340,300
+4,519
+1% +$180K ﹤0.01% 2856
2023
Q2 		$13.6M Buy
335,781
+41,765
+14% +$1.72M ﹤0.01% 2870
2023
Q1 		$12.3M Sell
294,016
-16,521
-5% -$695K ﹤0.01% 2940
2022
Q4 		$13.5M Sell
310,537
-14,253
-4% -$606K ﹤0.01% 2755
2022
Q3 		$12.6M Buy
324,790
+26,307
+9% +$1.12M ﹤0.01% 2713
2022
Q2 		$12.7M Buy
298,483
+20,903
+8% +$908K ﹤0.01% 2822
2022
Q1 		$12.6M Buy
277,580
+14,237
+5% +$631K ﹤0.01% 2630
2021
Q4 		$12.8M Buy
263,343
+14,082
+6% +$667K ﹤0.01% 2659
2021
Q3 		$11.9M Sell
249,261
-10,699
-4% -$521K ﹤0.01% 2690
2021
Q2 		$12.6M Sell
259,960
-27,034
-9% -$1.29M ﹤0.01% 2714
2021
Q1 		$13.3M Buy
286,994
+57,013
+25% +$2.7M ﹤0.01% 2358
2020
Q4 		$10.9M Buy
229,981
+5,659
+3% +$257K ﹤0.01% 2413
2020
Q3 		$9.61M Sell
224,322
-37,327
-14% -$1.6M ﹤0.01% 2067
2020
Q2 		$10.7M Buy
261,649
+27,900
+12% +$1.13M ﹤0.01% 1908
2020
Q1 		$8.43M Buy
233,749
+57,384
+33% +$2.29M ﹤0.01% 1932
2019
Q4 		$7.5M Buy
176,365
+4,650
+3% +$184K ﹤0.01% 2744
2019
Q3 		$6.57M Sell
171,715
-2,429
-1% -$93.5K ﹤0.01% 2581
2019
Q2 		$6.77M Buy
174,144
+14,526
+9% +$552K ﹤0.01% 2592
2019
Q1 		$6.35M Buy
159,618
+7,785
+5% +$308K ﹤0.01% 2476
2018
Q4 		$5.53M Buy
151,833
+29,345
+24% +$1.15M ﹤0.01% 2784
2018
Q3 		$5.21M Buy
122,488
+1,009
+0.8% +$40.9K ﹤0.01% 3148
2018
Q2 		$4.69M Sell
121,479
-12,305
-9% -$446K ﹤0.01% 3214
2018
Q1 		$4.68M Sell
133,784
-2,589
-2% -$92.1K ﹤0.01% 3095
2017
Q4 		$4.98M Buy
136,373
+5,532
+4% +$200K ﹤0.01% 3112
2017
Q3 		$4.77M Buy
130,841
+22,707
+21% +$826K ﹤0.01% 3009
2017
Q2 		$3.96M Sell
108,134
-20,759
-16% -$728K ﹤0.01% 3116
2017
Q1 		$4.46M Buy
128,893
+3,530
+3% +$119K ﹤0.01% 2966
2016
Q4 		$3.98M Sell
125,363
-3,806
-3% -$128K ﹤0.01% 3240
2016
Q3 		$4.44M Buy
129,169
+15,108
+13% +$534K ﹤0.01% 2776
2016
Q2 		$4.06M Buy
114,061
+5,097
+5% +$186K ﹤0.01% 2805
2016
Q1 		$3.86M Sell
108,964
-1,347
-1% -$47.6K ﹤0.01% 2766
2015
Q4 		$4.34M Sell
110,311
-5,885
-5% -$240K ﹤0.01% 2800
2015
Q3 		$4.36M Sell
116,196
-5,624
-5% -$249K ﹤0.01% 2777
2015
Q2 		$5.21M Sell
121,820
-8,758
-7% -$376K ﹤0.01% 2754
2015
Q1 		$5.62M Sell
130,578
-10,881
-8% -$454K ﹤0.01% 2651
2014
Q4 		$6.04M Buy
141,459
+37,197
+36% +$1.53M ﹤0.01% 2543
2014
Q3 		$4M Buy
104,262
+2,116
+2% +$77.9K ﹤0.01% 2825
2014
Q2 		$3.75M Buy
102,146
+11,970
+13% +$433K ﹤0.01% 2934
2014
Q1 		$3.34M Sell
90,176
-37,650
-29% -$1.39M ﹤0.01% 2974
2013
Q4 		$4.53M Buy
127,826
+4,685
+4% +$158K ﹤0.01% 2660
2013
Q3 		$4.01M Buy
123,141
+8,294
+7% +$275K ﹤0.01% 2641
2013
Q2 		$3.57M Buy
+114,847
New +$3.59M ﹤0.01% 2641

Other funds holding BME

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley's BME Position: Q1 2026 in Review

Morgan Stanley increased its BlackRock Health Sciences Trust (BME) stake by 3.5% in Q1 2026, buying an estimated $500K and bringing the position to 357,918 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3289.

Morgan Stanley first reported a position in BME in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.6M in Q4 2023. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Morgan Stanley held 357,918 shares of BlackRock Health Sciences Trust worth $13.8M as of Q1 2026.
  • Morgan Stanley bought 12,129 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $500K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3289 holding.
  • Morgan Stanley first reported a position in BlackRock Health Sciences Trust in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's BlackRock Health Sciences Trust position peaked at $30.6M in Q4 2023.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.